Male Breast Cancer Active Not Recruiting Phase 1 / 2 Trials for Everolimus (DB01590)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01783756Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS MetastasisTreatment